Table 2.
Antiretroviral drugs detected in men who were HIV infected at enrollment.
| Total | Previously diagnoseda | Newly diagnoseda | |
|---|---|---|---|
| ARV drug(s) detected | 60 | 34 | 26 |
|
| |||
| Consistent with recommended ARTb | 31 (52%) | 23 (68%) | 8 (31%) |
|
| |||
| Consistent with PI-based regimen | 24 | 18 | 6 |
| PI alone (ATV, LPV, DRV, or RTV) | 8 | 6 | 2 |
| PI (ATV, LPV, or DRV) ± RTV + NRTI(s)c | 16 | 12 | 4 |
| Consistent with NNRTI-based regimen | 7 | 5 | 2 |
| NVP alone | 3 | 2 | 1 |
| EFV alone | 1 | 1 | - |
| EFV + FTC | 3 | 2 | 1 |
|
| |||
| Not consistent with recommended ARTd | 29 (48%) | 11 (32%) | 18 (69%) |
|
| |||
| ZDV alone | 9 | 1 | 8 |
| NFV alone | 7 | 3 | 4 |
| FTC alone | 3 | 3 | - |
| TFV alone | 1 | 1 | - |
| IDV alone | 1 | - | 1 |
| FTC/TFV | 1 | - | 1 |
| 3TC + NFV | 1 | 1 | - |
| ZDV + NFV | 1 | - | 1 |
| NVP + APV | 1 | - | 1 |
| FTC/TFV + NFV | 1 | 1 | - |
| FTC/TFV + NFV + IDV | 1 | - | 1 |
| FTC/TFV + NFV + LPV + RTV | 1 | - | 1 |
| FTC/TFV + NFV + LPV + RTV + ZDV | 1 | 1 | - |
The table shows the patterns of antiretroviral (ARV) drugs detected among men who reported that they were previously diagnosed and among men who reported no prior HIV diagnosis (newly diagnosed). Men were tested for the presence of four nucleoside/nucleotide reverse transcription inhibitors (NRTIs), two non-nucleoside reverse transcription inhibitors (NNRTIs), and nine protease inhibitors (PIs, see Methods). Abbreviations: ATV: atazanavir; LPV: lopinavir; DRV: darunavir; RTV: ritonavir; NVP: nevirapine; EFV: efavirenz; FTC: emtricitabine; ZDV: zidovudine; NFV: nelfinavir; TFV: tenofovir; IDV: indinavir; 3TC: lamivudine; APV: amprenavir.
Men were asked whether they were aware of their HIV status at the time of study enrollment.
Criteria used to characterize ARV drugs as consistent with recommended ARV treatment (ART) regimens are described in the text.
The NRTIs detected were either FTC alone or with TFV, or 3TC.
This category includes patterns of ARV drug detection that were not consistent with recommended ART regimens. Drugs that were not recommended as part of pre-exposure prophylaxis, post-exposure prophylaxis, or ART regimens are underlined.